TY - JOUR AU - Weld, K. J. PY - 2000 DA - 2000// TI - Dmochowski. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury JO - Urology. VL - 55 ID - Weld2000 ER - TY - JOUR AU - Gao, Y. AU - Danforth, T. AU - Ginsberg, D. A. PY - 2017 DA - 2017// TI - Urologic management and complications in spinal cord injury patients: a 40- to 50-year follow-up study JO - Urology VL - 104 ID - Gao2017 ER - TY - JOUR AU - Groen, J. AU - Pannek, J. AU - Castro Diaz, D. AU - Popolo, G. AU - Gross, T. AU - Hamid, R. PY - 2016 DA - 2016// TI - Summary of European Association of Urology (EAU) guidelines on Neuro-urology JO - Eur Urol VL - 69 ID - Groen2016 ER - TY - JOUR AU - Madersbacher, H. AU - Mürtz, G. AU - Stöhrer, M. PY - 2013 DA - 2013// TI - Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics JO - Spinal Cord VL - 51 ID - Madersbacher2013 ER - TY - JOUR AU - Kessler, T. M. AU - Bachmann, L. M. AU - Minder, C. AU - Löhrer, D. AU - Umbehr, M. AU - Schünemann, H. J. PY - 2011 DA - 2011// TI - Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach JO - PLoS One VL - 6 ID - Kessler2011 ER - TY - JOUR AU - Buser, N. AU - Ivic, S. AU - Kessler, T. M. AU - Kessels, A. G. AU - Bachmann, L. M. PY - 2012 DA - 2012// TI - Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses JO - Eur Urol VL - 62 ID - Buser2012 ER - TY - JOUR AU - Madhuvrata, P. AU - Singh, M. AU - Hasafa, Z. AU - Abdel-Fattah, M. PY - 2012 DA - 2012// TI - Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analyses JO - Eur Urol VL - 62 ID - Madhuvrata2012 ER - TY - JOUR AU - Mangera, A. AU - Andersson, K. E. AU - Apostolidis, A. AU - Chapple, C. AU - Dasgupta, P. AU - Giannantoni, A. PY - 2011 DA - 2011// TI - Contemporary management of lower urinary tract disease with botulinum toxin a: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA) JO - Eur Urol VL - 60 ID - Mangera2011 ER - TY - JOUR AU - Cruz, F. AU - Herschorn, S. AU - Aliotta, P. AU - Brin, M. AU - Thompson, C. AU - Lam, W. PY - 2011 DA - 2011// TI - Efficacy and safety of onabotulinumtoxin in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial JO - Eur Urol VL - 60 ID - Cruz2011 ER - TY - JOUR AU - Ginsberg, D. AU - Gousse, A. AU - Keppenne, V. AU - Sievert, K. D. AU - Thompson, C. AU - Lam, W. PY - 2012 DA - 2012// TI - Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity JO - J Urol VL - 187 ID - Ginsberg2012 ER - TY - JOUR AU - Rovner, E. AU - Kohan, A. AU - Chartier-Kastler, E. AU - Jünemann, K. P. AU - Popolo, G. AU - Herschorn, S. PY - 2016 DA - 2016// TI - Long-term efficacy and safety of OnabotulinumtoxinA in patients with neurogenic detrusor Overactivity who completed 4 years of treatment JO - J Urol VL - 196 ID - Rovner2016 ER - TY - JOUR AU - Leitner, L. AU - Guggenbühl-Roy, S. AU - Knüpfer, S. C. AU - Walter, M. AU - Schneider, M. P. AU - Tornic, J. PY - 2016 DA - 2016// TI - More than 15 years of experience with Intradetrusor OnabotulinumtoxinA injections for treating refractory neurogenic detrusor Overactivity: lessons to be learned JO - Eur Urol VL - 70 ID - Leitner2016 ER - TY - JOUR AU - Baron, M. AU - Peyronnet, B. AU - Auble, A. AU - Hascoet, J. AU - Castel-Lacanal, E. AU - Miget, G. PY - 2019 DA - 2019// TI - Long-term discontinuation of Botulinum toxin a Intradetrusor injections for neurogenic detrusor Overactivity: a multicenter study JO - J Urol VL - 201 ID - Baron2019 ER - TY - JOUR AU - Joussain, C. AU - Popoff, M. AU - Phe, V. AU - Even, A. AU - Bosset, P. O. AU - Pottier, S. PY - 2018 DA - 2018// TI - Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin a injections for the treatment of refractory neurogenic detrusor overactivity JO - Neurourol Urodyn VL - 37 ID - Joussain2018 ER - TY - JOUR AU - Hegele, A. AU - Frohme, C. AU - Varga, Z. AU - Olbert, P. AU - Kranz, J. AU - Hofmann, R. PY - 2011 DA - 2011// TI - Antibodies after Botulinum toxin a injection into Musculus detrusor Vesicae: incidence and clinical relevance JO - Urol Int VL - 87 ID - Hegele2011 ER - TY - JOUR AU - Fabbri, M. AU - Leodori, G. AU - Fernandes, R. M. AU - Bhidayasiri, R. AU - Marti, M. J. AU - Colosimo, C. PY - 2016 DA - 2016// TI - Neutralizing antibody and Botulinum toxin therapy: a systematic review and meta-analysis JO - Neurotox Res VL - 29 ID - Fabbri2016 ER - TY - JOUR AU - Peyronnet, B. AU - Castel-Lacanal, E. AU - Manunta, A. AU - Roumiguié, M. AU - Marque, P. AU - Rischmann, P. PY - 2015 DA - 2015// TI - Failure of botulinum toxin injection for neurogenic detrusor overactivity: switch of toxin versus second injection of the same toxin JO - Int J Urol VL - 22 ID - Peyronnet2015 ER - TY - JOUR AU - Peyronnet, B. AU - Gamé, X. AU - Vurture, G. AU - Nitti, V. W. AU - Brucker, B. M. PY - 2018 DA - 2018// TI - Botulinum toxin use in Neurourology JO - Rev Urol VL - 20 ID - Peyronnet2018 ER - TY - JOUR AU - Karsenty, G. AU - Baverstock, R. AU - Carlson, K. AU - Diaz, D. C. AU - Cruz, F. AU - Dmochowski, R. PY - 2014 DA - 2014// TI - Technical aspects of botulinum toxin type a injection in the bladder to treat urinary incontinence: reviewing the procedure JO - Int J Clin Pract VL - 68 ID - Karsenty2014 ER - TY - JOUR AU - Koschorke, M. AU - Leitner, L. AU - Sadri, H. AU - Knüpfer, S. C. AU - Mehnert, U. AU - Kessler, T. M. PY - 2017 DA - 2017// TI - Intradetrusor onabotulinumtoxinA injections for refractory neurogenic detrusor overactivity incontinence: do we need urodynamic investigation for outcome assessment? JO - BJU Int VL - 120 ID - Koschorke2017 ER - TY - JOUR AU - Rosier, P. F. W. M. AU - Kuo, H. C. AU - Gennaro, M. AU - Gammie, A. AU - Finazzi Agro, E. AU - Kakizaki, H. PY - 2019 DA - 2019// TI - International consultation on in-continence 2016; executive summary: urodynamic testing JO - Neurourol Urodyn VL - 38 ID - Rosier2019 ER - TY - JOUR AU - D'Ancona, C. AU - Haylen, B. AU - Oelke, M. AU - Abranches-Monteiro, L. AU - Arnold, E. AU - Goldman, H. PY - 2019 DA - 2019// TI - Standardisation steering committee ICS and the ICS working group on terminology for male lower Urinary Tract & Pelvic Floor Symptoms and dysfunction the international continence society (ICS) re-port on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction JO - Neurourol Urodyn VL - 38 ID - D'Ancona2019 ER - TY - STD TI - Pannek J, Kennelly M, Kessler TM, Linsenmeyer T, Wyndaele JJ, Biering-Sørensen F. International spinal cord injury urodynamic basic data set (version 2.0). Spinal Cord Ser Cases. 2018; doi: https://doi.org/10.1038/s41394-018-0133-0. eCollection. ID - ref23 ER - TY - JOUR AU - Kirshblum, S. C. AU - Burns, S. P. AU - Biering-Sorensen, F. AU - Donovan, W. AU - Graves, D. E. AU - Jha, A. PY - 2011 DA - 2011// TI - International standards for neurological classification of spinal cord injury (revised 2011) JO - J Spinal Cord Med VL - 34 ID - Kirshblum2011 ER - TY - JOUR AU - Li, G. P. AU - Wang, X. Y. AU - Zhang, Y. PY - 2018 DA - 2018// TI - Efficacy and safety of OnabotulinumtoxinA in patients with neurogenic detrusor Overactivity caused by spinal cord injury: a systematic review and meta-analysis JO - Int Neurourol J VL - 22 ID - Li2018 ER - TY - JOUR AU - Pannek, J. AU - Göcking, K. AU - Bersch, U. PY - 2009 DA - 2009// TI - Long-term effects of repeated intradetrusor botulinum neurotoxin a injections on detrusor function in patients with neurogenic bladder dysfunction JO - BJU Int VL - 104 ID - Pannek2009 ER - TY - JOUR AU - Ni, J. AU - Wang, X. AU - Cao, N. AU - Si, J. AU - Gu, B. PY - 2018 DA - 2018// TI - Is repeat Botulinum toxin a injection valuable for neurogenic detrusor overactivity-a systematic review and meta-analysis JO - Neurourol Urodyn VL - 37 ID - Ni2018 ER - TY - JOUR AU - Schurch, B. AU - Sèze, M. AU - Denys, P. AU - Chartier-Kastler, E. AU - Haab, F. AU - Everaert, K. PY - 2005 DA - 2005// TI - Botox detrusor Hyperreflexia study team. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study JO - J Urol VL - 174 ID - Schurch2005 ER - TY - JOUR AU - Schulte-Baukloh, H. AU - Bigalke, H. AU - Miller, K. AU - Heine, G. AU - Pape, D. AU - Lehmann, J. PY - 2008 DA - 2008// TI - Botulinum neurotoxin type a in urology: antibodies as a cause of therapy failure JO - Int J Urol VL - 15 ID - Schulte-Baukloh2008 ER - TY - JOUR AU - Kennelly, M. AU - Dmochowski, R. AU - Ethans, K. AU - Karsenty, G. AU - Schulte-Baukloh, H. AU - Jenkins, B. PY - 2013 DA - 2013// TI - Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis JO - Urology VL - 81 ID - Kennelly2013 ER - TY - JOUR AU - Kennelly, M. AU - Dmochowski, R. AU - Schulte-Baukloh, H. AU - Ethans, K. AU - Popolo, G. AU - Moore, C. PY - 2017 DA - 2017// TI - On behalf of 191622-094 investigators. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: final results of a long-term extension study JO - Neurourol Urodyn VL - 36 ID - Kennelly2017 ER - TY - JOUR AU - Jankovic, J. AU - Vuong, K. D. AU - Ahsan, J. PY - 2003 DA - 2003// TI - Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia JO - Neurology VL - 60 ID - Jankovic2003 ER - TY - JOUR AU - Chen, S. F. AU - Kuo, H. C. PY - 2015 DA - 2015// TI - Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity JO - J Formos Med Assoc VL - 114 ID - Chen2015 ER - TY - JOUR AU - Peyronnet, B. AU - Gamé, X. PY - 2018 DA - 2018// TI - Failures and long-term discontinuations of intradetrusor botulinum toxin injections for neurogenic detrusor overactivity: a new challenge in neurourology JO - Neurourol Urodyn VL - 37 ID - Peyronnet2018 ER - TY - JOUR AU - Peyronnet, B. AU - Roumiguié, M. AU - Castel-Lacanal, E. AU - Guillotreau, J. AU - Malavaud, B. AU - Marque, P. PY - 2016 DA - 2016// TI - Preliminary results of botulinum toxin a switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity JO - Neurourol Urodyn VL - 35 ID - Peyronnet2016 ER - TY - JOUR AU - Bottet, F. AU - Peyronnet, B. AU - Boissier, R. AU - Reiss, B. AU - Previnaire, J. G. AU - Manunta, A. PY - 2018 DA - 2018// TI - Groupe d’Etude de Neuro-Urologie de langue Française (GENULF) and the committee of NeuroUrology of the French Association of Urology (AFU). Switch to Abobotulinum toxin a may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin a failed JO - Neurourol Urodyn VL - 37 ID - Bottet2018 ER - TY - JOUR AU - Haferkamp, A. AU - Schurch, B. AU - Reitz, A. AU - Krengel, U. AU - Grosse, J. AU - Kramer, G. PY - 2004 DA - 2004// TI - Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder JO - Eur Urol VL - 46 ID - Haferkamp2004 ER - TY - JOUR AU - Apostolidis, A. AU - Jacques, T. S. AU - Freeman, A. AU - Kalsi, V. AU - Popat, R. AU - Gonzales, G. PY - 2008 DA - 2008// TI - Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type a for the treatment of neurogenic or idiopathic detrusor overactivity JO - Eur Urol VL - 53 ID - Apostolidis2008 ER - TY - JOUR AU - Compérat, E. AU - Reitz, A. AU - Delcourt, A. AU - Capron, F. AU - Denys, P. AU - Chartier-Kastler, E. PY - 2006 DA - 2006// TI - Histologic features in the urinary bladder wall affected from neurogenic overactivity—a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type a JO - Eur Urol VL - 50 ID - Compérat2006 ER -